ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Comparison of QuantiFERON-TB Gold with Tuberculin Skin Test for Detecting Latent Tuberculosis Infection before Kidney Transplantation

C. Kim, H. Jung, K. Kim, J. Lim, O. Kwon, J. Choi, J. Cho, S. Park, Y. Kim

Divison of Nephrology, Department of Internal Medicine and Clinical Research Center for ESRD in Korea, Kyungpook National University Hospital, Daegu, Korea

Meeting: 2013 American Transplant Congress

Abstract number: B1043

Introduction: Screening for latent tuberculosis infection (LTBI) before kidney transplantation (KT) is indispensable process in kidney transplant recipients (KTRs). The purposes of this study were to compare the QuantiFERON-TB Gold In-Tube test (QFT-GIT) with the tuberculin skin test (TST) for the screening of LTBI in KTRs and to determine predictors correlating to results of each screening method.

Methods: We prospectively compared the results of QFT-GIT to TST in KTRs between July 2008 and July 2012. KTRs were screened for LTBI with both QFT-GIT and TST. Isoniazid (INH) prophylaxis was applied to KTRs with positive TST or positive QFT-GIT or clinical risk factors for LTBI. Post-transplant tuberculosis (TB) was diagnosed by obvious clinical evidence.

Results: A total of 97 patients were tested with QFT-GIT and TST during the study period (mean follow-up 24.6 ± 14.4month). Among them, 19 (20.4%) and 12 (12.9%) had positive QFT-GIT and TST results respectively, the overall agreement between tests was 79.3% (Κ=0.27, 95% confidence interval [CI] -0.03 to 0.50, P <0.014). The incidence of TB was 0.52 per 100 person-years (95% CI 0.02-3.68). No patients developed TB in INH prophylaxis group, whereas one patient in no prophylaxis group developed TB at 14 months after KT. Sensitivity of the two tests could not be compared because patient which showed positive result of QT-GIT or TST did not develop TB. The difference of specificity between QFT-GIT (79.3%) and TST (86.9%) was not statistically significant (P=0.167). Abnormal chest radiograph (OR 27.94, 95% CI 1.22-636.61, P=0.037) and positive TST (OR 7.65, 95% CI 1.75-33.30, P=0.007) were significantly associated with positive QFT-GIT results. Only positive QFT-GIT (OR 6.03, 95% CI 1.51-24.01, P=0.011) was associated with positive TST results.

Conclusions: QFT-GIT and TST for the diagnosis of LTBI in KTRs showed reasonable concordance between tests. However, it could not be determined superiority between QFT-GIT and TST.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kim C, Jung H, Kim K, Lim J, Kwon O, Choi J, Cho J, Park S, Kim Y. Comparison of QuantiFERON-TB Gold with Tuberculin Skin Test for Detecting Latent Tuberculosis Infection before Kidney Transplantation [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/comparison-of-quantiferon-tb-gold-with-tuberculin-skin-test-for-detecting-latent-tuberculosis-infection-before-kidney-transplantation/. Accessed May 14, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences